Montag & Associates’s Idexx Laboratories IDXX Stock Holding History

Montag & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$702K	Hold	1,250	–	–	0.03%	275
2025 Q4	$846K	Hold	1,250	–	–	0.04%	254
2025 Q3	$799K	Hold	1,250	–	–	0.04%	266
2025 Q2	$670K	Hold	1,250	–	–	0.03%	280
2025 Q1	$525K	Hold	1,250	–	–	0.03%	308
2024 Q4	$517K	Hold	1,250	–	–	0.02%	316
2024 Q3	$632K	Hold	1,250	–	–	0.03%	300
2024 Q2	$609K	Hold	1,250	–	–	0.03%	284
2024 Q1	$675K	Hold	1,250	–	–	0.03%	288
2023 Q4	$694K	Hold	1,250	–	–	0.04%	272
2023 Q3	$547K	Hold	1,250	–	–	0.03%	278
2023 Q2	$628K	Hold	1,250	–	–	0.04%	261
2023 Q1	$625K	Hold	1,250	–	–	0.04%	257
2022 Q4	$510K	Hold	1,250	–	–	0.03%	258
2022 Q3	$407K	Hold	1,250	–	–	0.03%	276
2022 Q2	$438K	Hold	1,250	–	–	0.03%	278
2022 Q1	$684K	Hold	1,250	–	–	0.04%	260
2021 Q4	$823K	Hold	1,250	–	–	0.04%	248
2021 Q3	$777K	Hold	1,250	–	–	0.04%	249
2021 Q2	$789K	Hold	1,250	–	–	0.04%	249
2021 Q1	$612K	Hold	1,250	–	–	0.03%	272
2020 Q4	$625K	Buy	+1,250	New	+$559K	0.04%	251

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Montag & Associates's IDXX Position: Q1 2026 in Review

Montag & Associates held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 1,250 shares worth $702K. The position accounts for 0.03% of the portfolio, ranked #275.

Montag & Associates first reported a position in IDXX in Q4 2020 and has held it in 22 quarters since. The position peaked at $846K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Montag & Associates held 1,250 shares of Idexx Laboratories worth $702K as of Q1 2026.
Montag & Associates left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up 0.03% of Montag & Associates's portfolio in Q1 2026, its #275 holding.
Montag & Associates first reported a position in Idexx Laboratories in Q4 2020 and has held it in 22 quarters since.
Montag & Associates's Idexx Laboratories position peaked at $846K in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.